101 related articles for article (PubMed ID: 26719029)
1. Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
Cook MT; Mafuvadze B; Besch-Williford C; Ellersieck MR; Goyette S; Hyder SM
Oncol Rep; 2016 Feb; 35(2):825-32. PubMed ID: 26719029
[TBL] [Abstract][Full Text] [Related]
2. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
3. Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
Mafuvadze B; Benakanakere I; López Pérez FR; Besch-Williford C; Ellersieck MR; Hyder SM
Cancer Prev Res (Phila); 2011 Aug; 4(8):1316-24. PubMed ID: 21505181
[TBL] [Abstract][Full Text] [Related]
4. Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.
Mafuvadze B; Cook M; Xu Z; Besch-Williford CL; Hyder SM
Nutr Cancer; 2013; 65(8):1184-91. PubMed ID: 24127693
[TBL] [Abstract][Full Text] [Related]
5. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
[TBL] [Abstract][Full Text] [Related]
6. Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.
Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
Endocr Relat Cancer; 2009 Mar; 16(1):85-98. PubMed ID: 19075036
[TBL] [Abstract][Full Text] [Related]
7. Additional effects of medroxyprogesterone acetate on mammary tumors in oophorectomized, estrogenized, DMBA-treated rats.
Sakamoto S; Kudo H; Suzuki S; Mitamura T; Sassa S; Kuwa K; Chun Z; Yoshimura S; Maemura M; Nakayama T; Shinoda H
Anticancer Res; 1997; 17(6D):4583-7. PubMed ID: 9494572
[TBL] [Abstract][Full Text] [Related]
8. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
[TBL] [Abstract][Full Text] [Related]
9. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.
Aldaz CM; Liao QY; LaBate M; Johnston DA
Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536
[TBL] [Abstract][Full Text] [Related]
10. Anti-progestins suppress the growth of established tumors induced by 7,12-dimethylbenz(a)anthracene: comparison between RU486 and a new 21-substituted-19-nor-progestin.
Wiehle RD; Christov K; Mehta R
Oncol Rep; 2007 Jul; 18(1):167-74. PubMed ID: 17549364
[TBL] [Abstract][Full Text] [Related]
11. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Samy RP; Gopalakrishnakone P; Ignacimuthu S
Chem Biol Interact; 2006 Dec; 164(1-2):1-14. PubMed ID: 17064676
[TBL] [Abstract][Full Text] [Related]
13. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
14. Trianthema portulacastrum Linn. exerts chemoprevention of 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats.
Bishayee A; Mandal A
Mutat Res; 2014 Oct; 768():107-18. PubMed ID: 24451939
[TBL] [Abstract][Full Text] [Related]
15. Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
Liang Y; Besch-Williford C; Brekken RA; Hyder SM
Cancer Res; 2007 Oct; 67(20):9929-36. PubMed ID: 17942925
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA).
Uchida M; Tsuboi H; Yamaji T; Murata N; Kohno T; Sugino E; Hibino S; Shimamura M; Oikawa T
Cancer Lett; 2000 Jun; 154(1):63-9. PubMed ID: 10799740
[TBL] [Abstract][Full Text] [Related]
17. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.
Cook MT; Liang Y; Besch-Williford C; Goyette S; Mafuvadze B; Hyder SM
Springerplus; 2015; 4():444. PubMed ID: 26312209
[TBL] [Abstract][Full Text] [Related]
19. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Banerjee S; Bueso-Ramos C; Aggarwal BB
Cancer Res; 2002 Sep; 62(17):4945-54. PubMed ID: 12208745
[TBL] [Abstract][Full Text] [Related]
20. Effects of hexestrol, medroxyprogesterone acetate and chlormadinone acetate on 7, 12-dimethylbenz [a] anthracene-induced rat mammary cancer in relation to estrogen receptor.
Tominaga T; Kitamura M; Saito T; Itoh I
Gan; 1981 Aug; 72(4):604-9. PubMed ID: 6171473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
